Replies to post #73113 on Muscle Pharm Corporation (MSLPQ)

[JimmyJams]

Last year they were still growing at an impressive clip with few drawbacks. This year they have had some blips. The Rollock stock buy-out, insurance not covering their expenses, cash draw down in Q4, etc.

I want to buy more and believe in what the management is saying, but I just can't get myself to. I have 10k shares at a much higher avg price (~$10.50). I need them to prove that they are in a sound cash position before I go and purchase more. I'm ok missing out on a $2-4 gain as the long run potential for this stock is much more than $20+ if they hit it right.

[StocksAnonymous]

Exactly,

1) IF there is minimal dilution

2) IF they grow sales 20% this year and don't "lose" money

3) If they ever get uplisted to NASDAQ and come to a resolution with the SEC...

They COULD certainly command a 2-3x sales valuation.

These IFs coming to fruition would lead to sales of $240 million and a valuation of $480 - $720 million.

Now, depending on their 4Q and 1Q results, we will know how realistic number 1 and 2 are. Number 3 remains the kicker that has been looming for 17 months now.